- 14 March
-
At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
- 22 January
-
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.
- 13 December
-
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week — 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.
- 04 October
-
On September 27, as part of the business program of the GMP conference with international participation, Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, took part in a Plenary Session on the issues of regulating the circulation of medicines in Russia and the EAEU, developing import independence, and increasing export potential. The session was attended by representatives of the Ministry of Industry and Trade of the Russian Federation, the Minister of Health of the Republic of Nicaragua, the WHO Representative in Russia, a Representative of the Serbian Ministry of Health and other Russian and foreign experts. Mr. Petrov spoke about the problems that Russian pharmaceutical companies face when entering international markets and suggested possible solutions.
- Home
- Cluster members
- TRONITEK LLC
TRONITEK LLC
The TRONITEK LLC company is engaged in the development and production of radio-electronic, medical and rehabilitation equipment. TRONITEK LLC has a high- tech production facilities, all manufactured products are subject to careful quality control. The main activity of the company is the development and production of high-tech medical products. The product range includes a whole line of universal and specialized devices for home and professional physiotherapy based on 2 technologies – dynamic electrical neurostimulation (DENS) and neuron-like dynamic electrical neurostimulation (NEURODENS).
DENS is a physiotherapy technique based on the impact on reflexogenous zones and acupuncture points with low- frequency short-pulse current for therapeutic and prophylactic purposes. Proven therapeutic effects: analgesic, anti-inflammatory, vascular, immunomodulatory, anti-stress.
NEURODENS is a medical technology based on the impact of weak pulse currents of a special sinusoidally damped shape, resembling a human nerve impulse, on biologically active zones and points in order to obtain specific therapeutic effects.
Specialized devices are designed for the treatment of acute and chronic pain in the joints, back, for the treatment of pain in the neck and shoulder girdle, for the correction of blood pressure, the correction of age-related changes in the skin of the face, etc.
Universal devices are used for the prevention and treatment of a wide range of diseases both at home and in health care institutions. Remote electrodes are used to increase the effectiveness of the impact on individual zones, reduce the complexity of self- care procedures.
The DENS and NEURODENS techniques have no age restrictions, and they are indicated to use on adults and children. For this technique, 40 doctoral and candidate works have been defended, more than 1000 scientific articles have been written, including 5 monographs and more than 20 recommended practices for medical practitioners. All this guarantees the high quality and efficiency of the manufactured devices.
